• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Pharmaceutical Market
Pharmaceutical News
Pharmaceutical Stocks
  • Pharmaceutical Market
  • Pharmaceutical News
  • Pharmaceutical Stocks
pharmaceutical investing

Infographic: Why Isn’t There a Cure for Cancer?

Written by Bryan Mc Govern
|
May. 22, 2017 03:30PM PST

Medical research has reached new levels that make us question when will we be able to cure one of the most serious diseases.

Cancer treatment continues to be a harrowing process for any patient, but medical improvements have been made to ease the treatment of this disease. However many often still ask when is a “cure” for cancer going to be found or made available to the masses.
The key element to know about any cure is that cancer isn’t simple, as a disease it can take many forms and affect very different parts of the body, so not many cancers are the same and the way to treat them varies from the types and the affected area.
Besides countless of large and small pharmaceutical companies working on a variety of treatments and different drugs to fight cancer, efforts in the US include a funded massive moonshot program that has put the goal to get cancer under a manageable situation, the program was created by former Vice President Joe Biden following the death of his son Beau Biden to brain cancer.


This year the government of Canada announced a partnership between The National Research Council of Canada and the Toronto-based Centre for the Commercialization of Antibodies and Biologics in order to accelerate cancer research and hopefully medical advancements.
“The goal of the collaboration is to identify the most promising antibodies, and increase their value by generating data that effectively de-risks each asset. CCAB’s objective is to then license lead antibody candidates to seed newly formed Canadian biotechnology companies,” said the press release.
The American Society of Clinical Oncology released a report on the most significant clinical growth combating the disease in 2016.
“Much work still lies ahead. Many questions remain about how cancer develops and spreads and how best to treat it… I hope you are as inspired as I am by the gains the clinical cancer research community has made over the past year and by the promise of a new era of advances just over the horizon,” said Dr. Daniel Hayes in the report.
That said, the Investing News Network took a look at the possibilities of significant improvements to cancer treatment under the Donald Trump presidency.
The below infographic from HealthGrad.com  details why there isn’t a direct cure for cancer.

Don’t forget to follow us @INN_LifeScience for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

pharmaceutical investing biotechnology companies canada cancer treatment cancer cells cancer research
The Conversation (0)

Go Deeper

AI Powered

Browse Topics

Microscopic view of stem cells.

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Latest News

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT

More News

Outlook Reports world

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
  • Energy
    • Uranium
    • Oil and Gas
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Industrial Metals
  • Agriculture
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Gaming
    • Cleantech
    • Emerging Tech
Life Science
    • Biotech
    • Cannabis
    • Psychedelics
    • Pharmaceuticals

Featured Pharmaceutical Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES